Screening for depression at the primary care level could dramatically increase the likelihood of treatment for those who are traditionally undertreated—racial and ethnic minority individuals, older ...

Impaired glucose signaling in the brain contributes to depression. Clinical trials demonstrate that reversing insulin ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient ...

Depression is a costly and debilitating condition that profoundly influences a person’s quality of life. In 2020, more than 21 million adults in the U.S. reported having at least one major depressive ...

Each morning during rounds as a resident at University of Rochester Medicine, Marika Toscano noticed the same troubling ...

Objectives To estimate the item-level conditional association network of depression, anxiety and stress symptoms in patients with non-Hodgkin’s lymphoma (NHL) during a prespecified chemotherapy ...

Research has drawn a clear line between obesity and depression — a patient with obesityis 33% more likely to have the condition. What’s unclear is which is the chicken and which is the egg. But in ...

A single day of treatment with an inhaled psychedelic compound called mebufotenin helped relieve symptoms of postpartum ...